Liraglutide or insulin glargine treatments improves hepatic fat in obese patients with type 2 diabetes and nonalcoholic fatty liver disease in twenty-six weeks: A randomized placebo-controlled trial
Wen Guo(Fujian Medical University), Wenjun Tian(Fujian Medical University), Lu Lin(Fujian Medical University), Xiangjin Xu(Fujian Medical University)
Cited by 115
Abstract
Related Papers
No related papers found
Powered by citation graph analysis